| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2007 | CN1902191A Amidopyrazole derivative |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902189A Plant-origin beta3-adrenoceptor agonist and use of the same |
| 01/24/2007 | CN1902186A Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors |
| 01/24/2007 | CN1902185A Thiazolidinones, their production and use as pharmaceutical agents |
| 01/24/2007 | CN1902182A Macrocyclic lactams and pharmaceutical use thereof |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902179A Methods and compositions for selectin inhibition |
| 01/24/2007 | CN1902178A Therapeutic agents useful for treating pain |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 01/24/2007 | CN1902173A Vitamin d3 lactam derivative |
| 01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1902169A 4-biarylyl-1-phenylazetidin-2-ones |
| 01/24/2007 | CN1902166A Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |
| 01/24/2007 | CN1902165A Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 01/24/2007 | CN1902161A Novel oxy-nitriles |
| 01/24/2007 | CN1902159A Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/24/2007 | CN1902158A N,N-dihalogenated amino acids and derivatives |
| 01/24/2007 | CN1902157A Process for the preparation of polymorphs of selective serotonin reuptake inhibitor |
| 01/24/2007 | CN1902156A Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901939A Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent |
| 01/24/2007 | CN1901938A Combination of a DPP-IV inhibitor and an anti-obesity or appetite regulating agent |
| 01/24/2007 | CN1901929A Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent |
| 01/24/2007 | CN1901928A Migraine remedy |
| 01/24/2007 | CN1901924A Method for inhibiting bacterial colonisation |
| 01/24/2007 | CN1901922A Compositions and uses thereof |
| 01/24/2007 | CN1901921A Baicalin and its derivatives as a treatment for SARS coronavirus infection or other related infections |
| 01/24/2007 | CN1901920A Food composition comprising glucosamine |
| 01/24/2007 | CN1901919A Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 01/24/2007 | CN1901918A Use of 3-aza-1-oxa-dibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1901916A Quinazolinone compounds with reduced bioaccumulation |
| 01/24/2007 | CN1901915A Method for treatment of multiple sclerosis |
| 01/24/2007 | CN1901914A Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors |
| 01/24/2007 | CN1901913A Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| 01/24/2007 | CN1901912A Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 01/24/2007 | CN1901911A Methods and compositions using thalidomide for the treatment and management of cancers and other diseases |
| 01/24/2007 | CN1901910A Substituted piperidines for the treatment of metabolic syndrome |
| 01/24/2007 | CN1901909A Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 01/24/2007 | CN1901908A Therapeutic compounds and uses thereof |
| 01/24/2007 | CN1901907A Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 01/24/2007 | CN1901906A Cci-779 for treating mantle cell lymphoma |
| 01/24/2007 | CN1901905A Intranasal compositions |
| 01/24/2007 | CN1901904A Use of 1,2-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1901903A Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901902A 噻吩和苯并噻吩异羟肟酸衍生物 Thiophene and benzothiophene derivatives of hydroxamic acid |
| 01/24/2007 | CN1901901A Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 01/24/2007 | CN1901900A Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 01/24/2007 | CN1901899A Methods of using and compositions comprising pde4 modulators for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901898A Treatment of neurodegenerative disease |
| 01/24/2007 | CN1901897A Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof |
| 01/24/2007 | CN1901896A Use of selected amino acid-zinc complexes as anti-malarials |
| 01/24/2007 | CN1901895A Methods of treating cancer with hdac inhibitors |
| 01/24/2007 | CN1901894A Inhibitor imaging agents |
| 01/24/2007 | CN1901893A Use of sulfonamide compounds for the treatment of diabetes and/or obesity |
| 01/24/2007 | CN1901892A Treating infectious diseases using ice inhibitors |
| 01/24/2007 | CN1901889A Oral formulation for 5-ht-receptor agonists, uses and methods of treatment employing the same |
| 01/24/2007 | CN1901888A Pharmaceutical compositions comprising lercanidipine |
| 01/24/2007 | CN1901884A Solid pharmaceutical dosage form |
| 01/24/2007 | CN1901881A Compositions and dosage forms for enhanced absorption |
| 01/24/2007 | CN1901880A Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 01/24/2007 | CN1901879A Administration of levodopa and carbidopa |
| 01/24/2007 | CN1901878A Microsphere of two anti-tubercular drugs and a biodegradable polymer administered by inhalation alone or combined with oral route, and process thereof |
| 01/24/2007 | CN1901863A Methods and reagents for the treatment of inflammatory disorders |
| 01/24/2007 | CN1901841A Composition and apparatus for transdermal delivery |
| 01/24/2007 | CN1901813A Use of hydroxyoleic acid and related compounds as functional food additives |
| 01/24/2007 | CN1900105A Compound with anti-tumor activity and its preparing method |
| 01/24/2007 | CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 01/24/2007 | CN1900100A Rehmannia root oligose and its extracting method |
| 01/24/2007 | CN1900094A Organic platinum new complex |
| 01/24/2007 | CN1900091A Nucleotide analog compositions |
| 01/24/2007 | CN1900090A Nucleotide analog compositions |
| 01/24/2007 | CN1900089A Nucleotide analog compositions |
| 01/24/2007 | CN1900087A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 01/24/2007 | CN1900081A Water soluble artemisine derivative and its preparing method, medicinal composition and use |
| 01/24/2007 | CN1900080A Inhibitors of cruzipain and other cysteine proteases |
| 01/24/2007 | CN1900079A New imidazole derivative, method for producing the same and use of the same |
| 01/24/2007 | CN1900078A Entecavir potassium salt compound and its preparing method and medicine use |
| 01/24/2007 | CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 01/24/2007 | CN1900076A Tetrahydro proto-berberine compounds, and their preparing method and use |
| 01/24/2007 | CN1900075A Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1900064A Synthesis and application of 6-(2-methoxy phenoxy)-1,4-dihydrogen-4-oxo-3-ethyl quinolinecarboxylate |
| 01/24/2007 | CN1900054A Substituted propion amide derivatives, their preparing method and use |
| 01/24/2007 | CN1900046A Kaurane diterpine compound and its preparing method and use |
| 01/24/2007 | CN1899643A Pessary or intrauterine medicine release device containing antiestrogenic and anti-pregnant hormone composite preparation and its use |
| 01/24/2007 | CN1899617A Compound econazole nitrate film forming gel composition and its use |
| 01/24/2007 | CN1899616A New use of non-receptor tyrosine kinase c-Ab1 specific inhibitor |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899606A Component for preventing and controlling heart diseases |
| 01/24/2007 | CN1899592A Wanhua oil Babu plaster for traumatic injury and preparing method |
| 01/24/2007 | CN1899591A Medicine for treating chronic bronchitis |
| 01/24/2007 | CN1899587A Plaster for treating scapulohumeral periarthritis, arthritis, etc. and its preparing method |
| 01/24/2007 | CN1899579A Synergistic medicinal composition |
| 01/24/2007 | CN1899578A Medicine for auxiliary treating hepatitis |